Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults

Clinical Endocrinology

Volumn 55, Issue 5, 2001, Pages 635-638

  Abdu, T A M ^a   Elhadd, T A ^a   Akber, M ^a   Hartland, A ^b   Neary, R ^b   Clayton, R N ^a,c  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^c CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; GROWTH HORMONE; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GROWTH HORMONE DEFICIENCY; HIP; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CREATININE; FEMALE; FOLIC ACID; GROWTH HORMONE; HOMOCYSTEINE; HUMANS; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; VITAMIN B 12;

EID: 0035724944     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01364.x     Document Type: Article

References (22)

1. Biophysical and biochemical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency
2. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
3. Insulin-like growth factors and vascular endothelium
4. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years
5. Folic acid responsive postmenopausal homocysteinaemia
6. Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
7. Hypopituitary females have a high incidence of cardiovascular morbidity and increased prevalence of cardiovascular risk factors
8. Increased cerebrovascular mortality in patients with hypopituitarism
9. Impaired endothelial function occurs in systemic arteries of children with homozygous homocysteinuria but not in their heterozygous parents
10. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency
11. Elevated plasma homocysteine levels are associated with enhanced oxidative stress and endothelial dysfunction in adult hypopituitary patients with growth hormone deficiency
12. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency
13. Homocysteine and hemostasis: Pathogenic mechanisms predisposing to thrombosis
14. High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults
15. Vascular dysfunction in monkeys with diet induced hyperhomocyst(e)inemia
16. Homocysteine and vascular disease: Nature or nurture?
17. Growth hormone treatment reverses early atherosclero-tic changes in GH-deficient adults
18. Premature mortality due to cardiovascular disease in hypopituitarism
19. Hyperhomocyst(e)inemia is associated with impaired endothelium dependent vasodilatation in humans
20. Direct demonstration of insulin-like growth factor-1 induced nitric oxide production by endothelial cells
21. Endothelium-dependent vascular effects of insulin and insulin-like growth factor-1 in the perfused rat mesenteric artery and aortic ring
22. Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: Is there a need for additional growth hormone substitution?